Validation and Method Development of Tadalafil in Bulk and Tablet Dosage Form by RP-HPLC

Abstract

A novel, precise, rapid and sensitive reverse phase high performance liquid chromatographic method has been developed for the validated estimation of Tadalafil in bulk and tablet dosage form. The separation was achieved on Agilent Eclipse XDB C₁₈ column (150 mm×4.6 mm, 5 µ) using a mobile phase that consists of the buffer (potassium dihydrogen orthophosphate) and acetonitrile in the ration of 50:50 V/V, pH 6 was adjusted with orthophosphoric acid. The flow rate was maintained at 1.2 ml/min and the detection wavelength was 285 nm. The method was validated for linearity, specificity, sensitivity as per ICH guidelines. The retention time was found to be 3.181 for Tadalafil. The calibration curve was linear over the concentration range of 10–150 µg/ml. The % RSD was satisfactory which showed the method found to be reliable. The high percentage recovery confirmed the suitability of the method for estimation of Tadalafil in pharmaceutical dosage form. The developed method could be applicable for routine analysis of Tadalafil in bulk and tablet dosage form.

Key words

RP-HPLC - tadalafil - method development - validation

• References

• 1 Pomerol JM, Rabasseda X. Tadalafil, a further innovation in the treatment of sexual dysfunction. Drugs Today (Barc) 2003; 39: 103-113
• 2 Francis SH, Corbin JD. Molecular mechanisms and pharmacokinetics of phosphodieterase- 5 antagonists. Curr Urol Rep 2003; 4: 457-465
• 3 Seftel AD. Phosphodiesterase type 5 inhibitor differentiation based on selectivity, pharmacokinetic, and efficacy profile. Clin Cardiol 2004; 27: 114-119
• 4 Bella AJ, Brock GB. Tadalafil in the treatment of erectile dysfunction. Curr Urol Rep 2003; 4: 472-478
• 5 Sutar AS, Magduma CS, Patilaand SS et al. RP-HPLC Estimation of Tadalafil in tablet dosage form. Int J Chem Sci 2008; 6: 1223-1227
• 6 Nikolaou P, Papoutsis I, Athanaselis S et al. Development and validation of a GC/MS method for the determination of Tadalafil in whole blood. J Pharm Biomed Anal 2011; 56: 577-81
• 7 Dhanu Radha SVV, Apparao KMCH, Ramakrishna K. New method development and validation of Tadalafil using UV-Visible spectrophotometer. Ijrrpas 2011; 1: 172-178
• 8 Prasanna reddy B, Amarnadh reddy K, Reddy MS. Validation and stability indicating RP-HPLC method for the determination of Tadalafil API in pharmaceutical formulations. RPB 2010; 2: 1-6
• 9 Lydia Rabbaa K, Rita Abi D. A sensitive and simple High performance liquid chromatograhic method for quantification of Tadalafil in human serum. The journal of Applied Research 2006; 6: 170-175
• 10 Satish Patel A, Natvarlal Patel J. High performance thin layer chromatographic method for determination of Tadalafil in tablet dosage form. AJPTR 2011; 1: 138-146
• 11 Vivek J, Anuj Modi Anurekha J, Shrivastava A et al. A Validated UV Spectrophotometric method for determination of Tadalafil in bulk and solid dosage form. JADR 2012; 2: 13-18
• 12 Edukondalu G, Mahaboob Subhani D, Bhaskar Raju N et al. A novel RP-HPLC method for the quantification of Tadalafil in formulations. Research desk 2012; 1: 66-73
• 13 Madhavi A, Reddy GS, Suryanarayana MV et al. Chiral separation of (r, r)-Tadalafil and its enantiomer in bulk drug samples and pharmaceutical dosage forms by chiral RP-HPLC. Chromatographia 2008; 67: 633-638
• 14 Hassan Y. Aboul-Enein, Imran Ali. Determination of Tadalafil in pharmaceutical preparation by HPLC using monolithic silica column. Int J Chem Sci 2008; 6: 1223-1227